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BACKGROUND 66 Colorectal cancer (CRC) is the second leading cause of cancer death worldwide.[1] CRC 67 screening by faecal occult blood test (FOBt) can reduce deaths. [2] In Scotland, since 2007, 68 people aged 50-74 have been mailed a self-complete FOBt every two years as part of the 69 Scottish Bowel Screening Programme. The FOBt requires people to collect two samples from 70 each of three separate bowel motions and to mail their completed kit for processing. Women 71 in Scotland are also invited to attend a pre-arranged appointment for breast screening using 72 mammography and to make an appointment for cervical screening using the Pap smear (Table   73 1). All three screening tests are offered at no cost to participants through the National Health 74 Service. Uptake of screening is 77% for cervical, 72% for breast but only 59% for colorectal 75 among women aged 50 and over. [3] [4] [5] Screening uptake rates show similar patterns in 76 Australia and the US with uptake of CRC screening lagging behind the participation rates of 77 breast and cervical screening. [6, 7] 78 Reasons for the low uptake of CRC screening include lack of awareness, feeling healthy, 79 negative views of cancer (fear, fatalism), negative attitudes towards colorectal tests, lack of 80 motivation including other health concerns, and cultural, gender and socioeconomic 81 influences. [8] [9] [10] [11] Many of these potential barriers also apply to breast and cervical 82 screening, [12] so it is unclear why CRC screening uptake should remain considerably lower. 83 There have been few comparisons of barriers across these three screening modalities. [13, 14] 84
We identified only one study that directly compared barriers to breast, cervical and CRC 85 screening uptake among women eligible for all three tests. [15] This British self-report survey 86 of 890 women found that among those who participated in breast and cervical but not 87 colorectal programmes, 23% reported not liking the idea of CRC screening test and 18% said 88 they 'haven't got round to it, but intend to take part' as explanations for non-participation in 89 CRC screening. [15] These explanations relate to both motivational influences such as dislike 90 of the test, and volitional aspects of 'not getting round to it', [16] the latter being particularly 91 salient for CRC screening which, unlike breast and cervical screening, is self-completed at 92 home. Our study adds to those data in three main respects. Firstly, rather than using self-93 reported data of screening history, we linked cancer screening uptake data for the breast, 94 cervical and CRC screening programmes for the complete population of Glasgow, Scotland-95 a socioeconomically diverse region with low overall screening uptake. Using this linked 96 dataset, we identified women with three different screening histories: i) participated in all 97 programmes; ii) participated in breast and cervical but not colorectal programmes; and iii) did 98 not participate in any programme. Secondly, we invited women across these three groups to 99 an individual in-depth interview, rather than a questionnaire, to provide the opportunity for 100 women to speak at length about their perceptions and experiences of cancer screening.
Thirdly, we organised our findings using the route MAP approach which is a useful tool to 102 summarise the central tenets of multiple models of behaviour change [17] . The MAP describes 103 three routes to behaviour: i) Motivation-strategies that increase and sustain motivation (e.g. 104 information about the behaviour, reassurance); Action-on-motivation-strategies that 105 strengthen and elaborate skills needed to translate motivations into action (e.g. setting 106 behavioural goals, action and coping planning); and Prompted or cued routes-strategies that 107 support behaviour change without the continuous cognitive effort required by the Motivation 108 and Action-on-motivation routes (e.g. prompt, change the environment to facilitate the target 109 behaviour). The MAP approach therefore provides a theoretically informed framework to 110 identify targets for intervention.
111
The present study was designed to 1) identify why women ( for the present study to select women who were eligible for breast, cervical and CRC screening (n=68,324). Because we expected screening experiences to differ by screening history and on 125 socioeconomic position we aimed to interview women in each of six groups (Table 2) .
126 Purposive sampling was used to randomly identify and invite to interview women with three 128 different screening histories: i) women who participated in all programmes (screening 129 participants); ii) women who participated in breast and cervical but not colorectal 130 programmes (CRC-specific non-participants); and iii) women who participated in none (non-131 participants). The sample was also stratified to obtain a mix of women from areas of high or 132 low socioeconomic deprivation ( 
RESULTS
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Sample characteristics 191 Of the 2,924 women sent an invitation to participate; 2,629 did not respond, 129 declined, 76 192 invitations were returned undelivered, four women had died, and 86 expressed an interest in 193 being interviewed of which four were excluded (due to becoming uncontactable, residing 194 primarily outside the UK, or having a stoma). In total, 61 interviews were scheduled and 59 195 women were interviewed. 196 Response rates varied considerably across the six groups; 55% of people who had participated 197 in all three programmes, and who lived in the least deprived areas agreed to be interviewed, 198 whereas only 0.9% of people who had participated in none of the programmes and lived in 199 the most deprived areas agreed to be interviewed ( Table 2 ). The respondents' age ranged 200 from 51 to 64 years. The respondents' views varied most commonly by screening participation 201 history (screening participants, CRC-specific non-participants, non-participants), which 202 formed our main comparison category. Comparisons by socioeconomic deprivation did not 203 show clear differences in respondents' views but are highlighted where differences were 204 found. 205 The results were organised into the three routes of behaviour change described by the MAP 206 approach: motivational challenges to CRC screening; action-on-motivation challenges to CRC 207 screening; and prompts to CRC screening. [17, 22] . The results are summarised in Table 3 . A key strength of our study was in achieving a sample of women whose screening histories 365 were objectively established by linking three cancer screening programmes' data for the entire population of Glasgow, Scotland. To our knowledge, this has not previously been done. 367 Among the CRC-specific non-participants and the non-participants the response rate to the 368 invitations to be interviewed was extremely low (0.9-5.3%) reflecting the difficulty of engaging 369 all population groups in research, and the value of the data that has been obtained. The study 370 has limitations; the SIMD measure used to assess socioeconomic deprivation was an area-371 based measure which offers a relatively blunt assessment and may offer one explanation for 372 the limited number of socioeconomic deprivation differences noted in the analysis. We have identified potential targets for interventions to increase CRC screening uptake and 408 drafted example policy recommendations ( in the study design, data collection or analysis, or the writing and publication of the report. 446 All researchers involved in this study were independent of the funder and all co-authors had 447 full access to all of the data (including statistical reports and tables) in the study and can take 448 responsibility for the integrity of the data and the accuracy of the data analysis. 449 We gratefully acknowledge the Patient Involvement support from Ann Muir and Tom Haswell. 
